LLY
Eli Lilly and Company
Platform & Compounding FCF
A-
86.4 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
24.0%
-
Operating Margin Trend
+4.26 pp/yr
-
5yr Avg ROE
64.4%
-
5yr Share-Count CAGR
-1.3%
-
5yr Revenue CAGR
21.6%
-
5yr EPS CAGR
28.8%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
9.6%
-
5yr FCF/NI Conversion
0.38x
-
Net Debt / EBITDA
1.11x
-
Interest Coverage (EBIT/Int)
37.34x
-
Altman Z-Score
10.32
Stability
Weight: 5%
C
52
-
EPS Volatility (σ/μ)
0.81
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
7
6 of 6 gurus held; 1 new buy; 3 added; 1 trimmed; 1 full exit.
- Holders
- 6
+1
- Avg Δ position
-
+9.6%
- New buys
- 1
- Full exits
- 1